(Reuters) - The FDA had already granted Novartis tentative approval in
December. Exforge was approved in January 2007 in the European
Union and has already been made available in nine EU countries,
with further launches planned.
Read more at Reuters.com Government Filings News
December. Exforge was approved in January 2007 in the European
Union and has already been made available in nine EU countries,
with further launches planned.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment